,:n*#

Gdishman
28th March,2017

To,
Department of Corporate Services
Bombay Stock Exchange Ltd.
Phiroze Jeejeebhoy Towers,
DalalStreet,
Mumbai - 400 001.

Ref.: Scrip Code No. : 532526

Sub. : Clarification pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015

Ref.: You're Letter No. L/SURV/ONL/RV/ZS12O16-17/299 dated 28th March, 2017 regarding
Confirmation/Confirmation on news item appearing in "CNBC TV18"

Dear Sir/Madam,

With reference to your letter no. L/SURV/ONL/RV/ZS\2O16-17\299 dated 28th March, 2017
regarding Confirmation/Confirmation on news item appearing in "CNBC TV18', we would like to
clarify on the same as under:

"We are a Global Contract Research and Manufacturing Services ("CRAMS') company
specializing in developing and manufacturing Active Pharmaceutical lngredients ("APls") for our
customers. Currently, we have about thirteen molecules in late phase lll development across
various customers. We, as an API supplier, are bound by strict confidentiality agreements with
our customers and will not have any prior knowledge of the stage of development of the
customer's end product. We believe that the increase in the stock price is based upon market
estimation that we are one of the suppliers of the API for "Zejula" capsules, which got approved
by the US FDA as per the press release given by Tesaro lnc.

Since the company does not manufacture the innovator's end product in CRAMS segment, it is
Tesaro lnc., which has received the US FDA approval for cancer drug Zejula Capsules and not
Dishman Pharmaceuticals and Chemicals Limited, as mentioned in the news item, which
appeared on CNBC TV18 dated March 28,2017.'
The Company has always been fully compliant and inform to Stock Exchanges of such
information which is required under regulation 30 of SEBI (LODR) Regulation,2015.

Hope the above clarifications will satisfy your requirements. lf you need any further clarification
kindly inform to us.

Thanking you.
Yours faithfully,
Chemicats Limited

Company Secretary

Phormoceulicols ond Chemicols Limited

Regisiered Office: Bhodr-Roi Chombers, Swostik Cross Roods, Novrongpuro, Ahmedobod - 380
Tel: +9i (O) 79 26443053 / 26445807 Fox +91 (Ol 79 26420198
Emoil: dishmon@dishmongroup.com Web: www.dishmongroup.com
Governmenl Recognised Export House
crN No 124230GJ1 983P1C006329